BALCAO · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP
Vaso Corporation VASO
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$89.1M
▲ 2.7% vs FY2024
EPS · FY25
$0.01
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
5.5%
Net margin · FY25
1.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 89.1M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
2 cents of every revenue dollar became profit this year.
Per share
USD 0.01
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
5.5%
Return on equity, FY2025
ROE
Operating margin-3.2%
Net margin1.8%
Return on assets1.8%
Each USD of equity produced 5 cents of profit this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+5.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+4.0%
+5.0%
+4.6%
+12.0%
Net income
−48.2%
+34.4%
−8.5%
EPS, diluted
−45.0%
−6.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.18B
Shares outstanding, FY2025
Change, 5 years+0.6%
Change, 10 years+11.1%
The share count grew 1% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 88.3M
total assets, end of FY2025
Total assetsUSD 88.3M
EquityUSD 29.4M
CashUSD 35.0M
Gross debtUSD 286,000.00
Net debtUSD -34.8M
Current ratio1.59×
The company holds more cash than debt.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
−0.0
EBITDA $B
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
·
−0.0
Income tax $B
−0.0
0.0
0.0
−0.0
0.0
0.0
0.0
−0.0
0.0
0.0
−0.0
0.0
−0.0
0.0
·
0.0
Net income $B
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
−0.0
EPS, diluted $
0.01
0.01
0.03
0.06
·
0.00
0.00
−0.02
−0.03
0.01
0.02
0.01
−0.01
−0.02
0.02
−0.04
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
5.5
3.5
19.6
68.1
75.5
7.6
−8.9
·
·
·
·
·
·
·
·
·
Shares out B
0.18
0.18
0.18
0.18
0.18
0.17
0.17
0.17
0.17
0.16
0.16
0.16
0.16
0.16
0.15
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
59 of 59
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed